1![IMMUNOTHERAPY AND MELANOMA RESEARCH GET BIG BOOST WITH BLOOMBERG-KIMMEL INSTITUTE Washington,
DC,
March
30,
2016
–The
promising
field
of
immunotherapy,
in
which
mela IMMUNOTHERAPY AND MELANOMA RESEARCH GET BIG BOOST WITH BLOOMBERG-KIMMEL INSTITUTE Washington,
DC,
March
30,
2016
–The
promising
field
of
immunotherapy,
in
which
mela](https://www.pdfsearch.io/img/4b053cb35b21cfef7670749f2c57bdad.jpg) | Add to Reading ListSource URL: www.curemelanoma.org- Date: 2016-03-30 14:45:05
|
---|
2![Theranostics 2016, Vol. 6, Issue 10 Ivyspring International Publisher Research Paper Theranostics 2016, Vol. 6, Issue 10 Ivyspring International Publisher Research Paper](https://www.pdfsearch.io/img/529b7cd80a134376e58fec4e83572046.jpg) | Add to Reading ListSource URL: www.thno.orgLanguage: English - Date: 2016-07-01 02:17:18
|
---|
3![I am writing to you on behalf of the staff at the Animal Health Trust (AHT). Their letter below informs Golden Retriever owners of important research investigating cancer in the breed and how they can contribute. The Ken I am writing to you on behalf of the staff at the Animal Health Trust (AHT). Their letter below informs Golden Retriever owners of important research investigating cancer in the breed and how they can contribute. The Ken](https://www.pdfsearch.io/img/5c3909b9cc4111b994a737509d891838.jpg) | Add to Reading ListSource URL: midlandgrc.esy.esLanguage: English - Date: 2015-11-10 15:09:48
|
---|
4![Microsoft Word - A snapshot of 20 years of medical research discovery and success.docx Microsoft Word - A snapshot of 20 years of medical research discovery and success.docx](https://www.pdfsearch.io/img/5ff563b77d23a23091bb0ca4dc604643.jpg) | Add to Reading ListSource URL: aamri.org.auLanguage: English - Date: 2014-06-15 21:24:15
|
---|
5![A Race between Tumor Immunoescape and Genome Maintenance Selects for Optimum Levels of (epi)genetic Instability Shingo Iwami1., Hiroshi Haeno2., Franziska Michor2* 1 PRESTO, Japan Science and Technology Agency, Graduate A Race between Tumor Immunoescape and Genome Maintenance Selects for Optimum Levels of (epi)genetic Instability Shingo Iwami1., Hiroshi Haeno2., Franziska Michor2* 1 PRESTO, Japan Science and Technology Agency, Graduate](https://www.pdfsearch.io/img/d3d2839910f71595d60ce926bca9eabc.jpg) | Add to Reading ListSource URL: michorlab.dfci.harvard.eduLanguage: English - Date: 2012-02-17 13:36:26
|
---|
6![A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon compared with healthy controls Petr Pancoska1, Jo A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon compared with healthy controls Petr Pancoska1, Jo](https://www.pdfsearch.io/img/82b81b15485b76c71ae2ef72195c499a.jpg) | Add to Reading ListSource URL: iti.mff.cuni.czLanguage: English - Date: 2016-02-04 05:53:39
|
---|
7![Joanna M. Nicolay Melanoma Foundation 255 Clifton Blvd., Suite 203 Westminster, Maryland4890 Email: Web: www.melanomaresource.org Joanna M. Nicolay Melanoma Foundation 255 Clifton Blvd., Suite 203 Westminster, Maryland4890 Email: Web: www.melanomaresource.org](https://www.pdfsearch.io/img/e94a2a16981d80522faa922b77cd0779.jpg) | Add to Reading ListSource URL: www.melanomaresource.orgLanguage: English - Date: 2011-03-30 13:15:45
|
---|
8![Postdoctoral position available at the CRCL in Lyon A postdoctoral position is available in the laboratory of Alain Puisieux at the Cancer Research Center in Lyon, within a group dedicated to melanoma research, composed Postdoctoral position available at the CRCL in Lyon A postdoctoral position is available in the laboratory of Alain Puisieux at the Cancer Research Center in Lyon, within a group dedicated to melanoma research, composed](https://www.pdfsearch.io/img/d1174e304acea9124c4d7a1f6bd02e66.jpg) | Add to Reading ListSource URL: www.crcl.frLanguage: English - Date: 2014-05-09 05:44:20
|
---|
9![Award ID: DP150099 Project Title: Immunotherapy targeting triple negative breast cancer using NY-ESO-1specific TCRs and blockade of immune suppression Award Mechanism: Bridging the Gap: Early Translational Research Award Award ID: DP150099 Project Title: Immunotherapy targeting triple negative breast cancer using NY-ESO-1specific TCRs and blockade of immune suppression Award Mechanism: Bridging the Gap: Early Translational Research Award](https://www.pdfsearch.io/img/4e8ac11dd5e1128ebb3e8bd7c0d56e63.jpg) | Add to Reading ListSource URL: www.cprit.state.tx.usLanguage: English - Date: 2014-11-20 01:49:44
|
---|
10![Award ID: DP150051 Project Title: Targeting the DC-HIL Receptor for Anti-Cancer Immunotherapy Award Mechanism: Bridging the Gap: Early Translational Research Awards Award ID: DP150051 Project Title: Targeting the DC-HIL Receptor for Anti-Cancer Immunotherapy Award Mechanism: Bridging the Gap: Early Translational Research Awards](https://www.pdfsearch.io/img/8ba764faf9e3eaead797cd16c2840af8.jpg) | Add to Reading ListSource URL: www.cprit.state.tx.usLanguage: English - Date: 2014-11-20 01:49:27
|
---|